These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7647342)

  • 1. ErbB-2 oncoprotein overexpression in breast carcinoma: inverse correlation with biochemically- and immunohistochemically-determined hormone receptors.
    Keshgegian AA
    Breast Cancer Res Treat; 1995 Aug; 35(2):201-10. PubMed ID: 7647342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. erbB-2 oncoprotein expression in breast carcinoma. Poor prognosis associated with high degree of cytoplasmic positivity using CB-11 antibody.
    Keshgegian AA; Cnaan A
    Am J Clin Pathol; 1997 Oct; 108(4):456-63. PubMed ID: 9322600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.
    Jalava P; Kuopio T; Huovinen R; Laine J; Collan Y
    Anticancer Res; 2005; 25(3c):2535-42. PubMed ID: 16080489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-erbB-2, p53 protein expression and steroid hormone receptors in breast carcinomas: an immunohistochemical study.
    Yokota T; Imamura M; Teshima S; Suzuki H; Tezuka F; Kikuchi S; Kunii Y; Yamauchi H
    Anticancer Res; 1999; 19(5B):4007-12. PubMed ID: 10628345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia.
    Arafah M
    Turk Patoloji Derg; 2012; 28(1):38-43. PubMed ID: 22207430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of predictive biomarkers in routine histopathological reporting of infiltrating ductal breast carcinoma in a tertiary hospital in Malaysia with a focus on limitations and directions for future development.
    Teoh KH; Looi LM; Sabaratnam S; Cheah PL; Nazarina AR; Mun KS
    Malays J Pathol; 2011 Jun; 33(1):35-42. PubMed ID: 21874750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L; Baker H; Sinowatz F
    Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53, c-erbB-2 expression and steroid hormone receptors in breast carcinoma: correlations with histopathological parameters.
    Kilinç N; Yaldiz M
    Eur J Gynaecol Oncol; 2004; 25(5):606-10. PubMed ID: 15493177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.
    Stierer M; Rosen H; Weber R; Hanak H; Spona J; Tüchler H
    Ann Surg; 1993 Jul; 218(1):13-21. PubMed ID: 8328824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases.
    Desouki MM; Atta IS; Wolff DJ; Self SE
    Turk Patoloji Derg; 2016; 32(3):178-85. PubMed ID: 27562392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
    Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
    Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.
    Bieche I; Parfait B; Le Doussal V; Olivi M; Rio MC; Lidereau R; Vidaud M
    Cancer Res; 2001 Feb; 61(4):1652-8. PubMed ID: 11245479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu.
    Bouras T; Southey MC; Venter DJ
    Cancer Res; 2001 Feb; 61(3):903-7. PubMed ID: 11221879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.
    Ferrero-Poüs M; Hacène K; Bouchet C; Le Doussal V; Tubiana-Hulin M; Spyratos F
    Clin Cancer Res; 2000 Dec; 6(12):4745-54. PubMed ID: 11156229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
    Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
    Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of estrogen and progesterone receptors and HER-2 by breast cancer cells].
    Zaĭrat'iants OV; Kolobov SV; Akopian IG; Opalenov KV; Barsanova TG
    Arkh Patol; 2004; 66(5):9-12. PubMed ID: 15575377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [C-erbB-2 oncogene amplification in breast cancer in correlation to steroid and epidermal growth factor receptor].
    Manavi M; Czerwenka KF; Zeillinger R; Speiser P; Kury F; Steinhart U; Peschke M; Kubista E; Reinold E
    Zentralbl Gynakol; 1992; 114(2):82-5. PubMed ID: 1350129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement.
    Sofi GN; Sofi JN; Nadeem R; Shiekh RY; Khan FA; Sofi AA; Bhat HA; Bhat RA
    Asian Pac J Cancer Prev; 2012; 13(10):5047-52. PubMed ID: 23244108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.
    Niemeier LA; Dabbs DJ; Beriwal S; Striebel JM; Bhargava R
    Mod Pathol; 2010 Feb; 23(2):205-12. PubMed ID: 19898421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.